NO20070565L - Kinolin tiazolinoner med CDK1 antiproliferativ aktivitet - Google Patents

Kinolin tiazolinoner med CDK1 antiproliferativ aktivitet

Info

Publication number
NO20070565L
NO20070565L NO20070565A NO20070565A NO20070565L NO 20070565 L NO20070565 L NO 20070565L NO 20070565 A NO20070565 A NO 20070565A NO 20070565 A NO20070565 A NO 20070565A NO 20070565 L NO20070565 L NO 20070565L
Authority
NO
Norway
Prior art keywords
quinoline
antiproliferative activity
thiazolinones
cdk1
cdk1 antiproliferative
Prior art date
Application number
NO20070565A
Other languages
English (en)
Norwegian (no)
Inventor
Shaoqing Chen
Li Chen
Christophe Michoud
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20070565L publication Critical patent/NO20070565L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20070565A 2004-07-01 2007-01-30 Kinolin tiazolinoner med CDK1 antiproliferativ aktivitet NO20070565L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58493104P 2004-07-01 2004-07-01
US65827305P 2005-03-03 2005-03-03
PCT/EP2005/006806 WO2006002828A1 (en) 2004-07-01 2005-06-23 Quinoline thiazolinones with cdk1 antiproliferative activity

Publications (1)

Publication Number Publication Date
NO20070565L true NO20070565L (no) 2007-02-08

Family

ID=34971310

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070565A NO20070565L (no) 2004-07-01 2007-01-30 Kinolin tiazolinoner med CDK1 antiproliferativ aktivitet

Country Status (18)

Country Link
US (1) US7250515B2 (de)
EP (1) EP1771443B1 (de)
JP (1) JP2008504323A (de)
KR (1) KR100856363B1 (de)
CN (1) CN1976927A (de)
AR (1) AR049539A1 (de)
AT (1) ATE420086T1 (de)
AU (1) AU2005259511A1 (de)
BR (1) BRPI0512843A (de)
CA (1) CA2571732A1 (de)
DE (1) DE602005012273D1 (de)
ES (1) ES2317238T3 (de)
IL (1) IL180097A0 (de)
MX (1) MXPA06015026A (de)
NO (1) NO20070565L (de)
RU (1) RU2007103706A (de)
TW (1) TW200610764A (de)
WO (1) WO2006002828A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008545690A (ja) * 2005-05-23 2008-12-18 スミスクライン・ビーチャム・コーポレイション 新規化合物
JP2008542328A (ja) * 2005-06-02 2008-11-27 エフ.ホフマン−ラ ロシュ アーゲー Gaba−bエンハンサーとしての3−メタンスルホニルキノリン
TW200716580A (en) * 2005-06-08 2007-05-01 Smithkline Beecham Corp (5Z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiazol-4(5H)-one
AR060391A1 (es) * 2006-04-11 2008-06-11 Smithkline Beecham Corp Compuestos de quinolin tiazolidinadiona, sustituidos con heterociclos, composiciones farmaceuticas que los contienen y usos para preparar medicamentos que inhiben la actividad de pi3 quinasas.
US20100286041A1 (en) * 2007-03-22 2010-11-11 Smithkline Beecham Corporation (5z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiazol-4(5h)-one
US20080255115A1 (en) * 2007-04-11 2008-10-16 Michael Gerard Darcy Thiazolidinedione derivatives as pi3 kinase inhibitors
TW200902008A (en) * 2007-05-10 2009-01-16 Smithkline Beecham Corp Quinoxaline derivatives as PI3 kinase inhibitors
PE20090717A1 (es) * 2007-05-18 2009-07-18 Smithkline Beecham Corp Derivados de quinolina como inhibidores de la pi3 quinasa
CN107098898B (zh) * 2016-02-19 2020-01-07 湖南大学 氮杂环氨基噻唑甲基喹啉酮衍生物及其制备方法与应用
WO2022113003A1 (en) 2020-11-27 2022-06-02 Rhizen Pharmaceuticals Ag Cdk inhibitors
WO2022149057A1 (en) 2021-01-05 2022-07-14 Rhizen Pharmaceuticals Ag Cdk inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1215208B1 (de) * 1997-10-27 2006-07-12 Agouron Pharmaceuticals, Inc. 4-Aminothiazol Derivate, deren Herstellung und deren Verwendung als Inhibitoren Cyclin-abhängiger Kinasen
KR20050085115A (ko) * 2002-11-22 2005-08-29 스미스클라인 비참 코포레이션 신규 화합물

Also Published As

Publication number Publication date
BRPI0512843A (pt) 2008-04-08
TW200610764A (en) 2006-04-01
IL180097A0 (en) 2007-05-15
KR100856363B1 (ko) 2008-09-04
WO2006002828A1 (en) 2006-01-12
ES2317238T3 (es) 2009-04-16
EP1771443A1 (de) 2007-04-11
AU2005259511A1 (en) 2006-01-12
KR20070027656A (ko) 2007-03-09
US20060004046A1 (en) 2006-01-05
MXPA06015026A (es) 2007-02-08
CA2571732A1 (en) 2006-01-12
CN1976927A (zh) 2007-06-06
EP1771443B1 (de) 2009-01-07
US7250515B2 (en) 2007-07-31
RU2007103706A (ru) 2008-08-10
AR049539A1 (es) 2006-08-09
JP2008504323A (ja) 2008-02-14
DE602005012273D1 (de) 2009-02-26
ATE420086T1 (de) 2009-01-15

Similar Documents

Publication Publication Date Title
SG170785A1 (en) Benzothiazoles having histamine h3 receptor activity
NO20093200L (no) Tiazolidinderivater
NO20043176L (no) Nikotinamidderivater nyttige som P38 inhibitorer
NO20060110L (no) Spesifik glukokortikosteroid forbindelse med anti-inflammatorisk aktivitet
NO20082388L (no) Heteroaryl substituerte piperidinderivater som L-CPT1 inhibitorer
NO20071593L (no) Pyrimidinderivater
NO20070532L (no) Substituerte 2-alkyl-kinazolinonderivater som PARP-inhibitorer
NO20070529L (no) Kinazolindionderivater som parp-inhibitorer
NO20050870L (no) Fosfodiesterase 4-inhibitorer, inkludert N-substituerte anilin- og difenylaminanaloger
NO20064282L (no) Morfolinforbindelser
NO20071843L (no) Substituerte anilinderivater
NO20073663L (no) Tiazol-4-karboksamid-derivater som mGluR5 antagonister
EA200601686A1 (ru) Замещенные производные морфолина и тиоморфолина
NO20054852L (no) GFAT inhibitorer
CY1112886T1 (el) Ανοσοκατασταλτικος παραγοντας ο οποιος περιλαμβανει μια ετεροκυκλικη ενωση ως δραστικο συστατικο
NO20080164L (no) N-(pyridin-2-yl)-sulfonamidderivater
NO20070564L (no) Kinoliner uten tiazolinonsubstituenter.
AR045959A1 (es) Derivados de pirazolo- e imidazo-pirimidina
ATE346067T1 (de) Carbolinderivate
NO20044526L (no) Hemisterlinderivater og anvendelser derav
ATE355265T1 (de) Biphenylcarboxamidderivate und ihre verwendung als p38 kinase inhibitoren
BR0313385A (pt) Derivados de pirimidina-2,4-diona como inibidores de metaloproteinase da matriz
NO20080033L (no) Kinolinderivater som NK3-antagonister
ATE413392T1 (de) Kondensierte heteroyralderivate und deren verwendung als p38-kinase-inhibitoren
ATE553106T1 (de) Heteroarylpyrrolopyridinone als kinaseinhibitoren

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application